Diabetes patients on dulaglutide (Trulicity) had better glycemic control and more weight loss if they switched to tirzepatide ...

GLP-1 agonists may lead to increased nausea and vomiting in the early postoperative period after total hip arthroplasty, ...

A real-world study finds cardiovascular and survival benefits from dual therapy in patients with type 2 diabetes.

To prevent muscle loss, more physicians are emphasizing the importance of fat loss vs weight loss for patients taking GLP-1 ...

The study finds better A1c lowering and weight reduction, but an expert clinician says practical issues may pose barriers.